UICC President-elect Election 2026: Meet the Candidates
FDA Grants Fast Track Designation to Nuvation Bio’s Safusidenib for IDH1-Mutant Glioma
INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma
FDA Seeks Public Feedback on Regulation of Generative AI-Enabled Medical Devices
Harold P. Freeman, Pioneer of Patient Navigation and Health Equity, Dies at 93
Early Bird Registration Is Now Open for the 7th Emirates Oncology Society Annual Conference 2026
Noubar Afeyan: Moderna and Merck Announce Positive Phase 3 Results in Melanoma
Muna Al-Khaifi: Menopausal Symptoms and Quality of Life After Cancer
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez […]
The ESMO Guidelines: Real World Cases – Rectal Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place on 29 July 2026 at 18:30 CEST. The session will use a real-world case to explore current ESMO recommendations for rectal cancer, including multimodality treatment, total neoadjuvant therapy, organ preservation, surgical strategies, […]
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […]
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom. This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and […]
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases, from diagnosis to treatment, according to current […]
The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. Awarding 60 ECTS credits upon completion, the programme combines 10 online modules, two in-person seminars, […]
The European School of Oncology's Refresher Course on Sarcoma is an advanced educational event taking place from 25 to 27 September 2026 in Rome, Italy. Organized in collaboration with the Università Campus Bio-Medico di Roma, the program is led by Course Chair Sylvie Bonvalot (FR), Host Chair Bruno Vincenzi (IT), and College Representative Silvia Brotea-Mosoiu […]
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 in Lugano, Switzerland. The course will focus on managing cancer-related symptoms, cachexia, nutritional needs, treatment toxicities, palliative care, end-of-life preparation, and communication with patients and […]
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […]
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona, Spain, from November 11–12, 2026. This specialized educational program is co-chaired by Simon Ekman, Lizza Hendriks, and Natasha Leighl, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies […]
The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18, 2026, in Berlin, Germany. This congress is designed as a central meeting point that facilitates the exchange of the latest research, promotes ethical dialogue, and highlights technological innovation in cancer care. It brings together healthcare and digital health experts from around […]
The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals, scheduled for December 4-6, 2026, in Singapore. Organized by the European Society for Medical Oncology (ESMO), this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major […]
The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO), scheduled for December 14–16, 2026, as an onsite event in London, United Kingdom, with an online option also available. The congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology, covering the […]
